Table 1.
Baseline characteristics of all patients
| Variable | ||
|---|---|---|
| Age (mean ± SD, range) (min.-max. Years) | 65.58 ± 12.33 (27–88) | |
| BMI (mean ± SD, range) (kg/m2) | 26.31 ± 5.41 | |
| Count of retrieved lymph nodes (mean ± SD, range) (min.-max.) | 19.89 ± 9.69 (3–70) | |
| Gender | Male | 117 (53.7%) |
| Female | 101 (46.3%) | |
| ASA score | I | 23 (10.6%) |
| II | 105 (48.2%) | |
| III | 87 (39.9%) | |
| IV | 3 (1.4%) | |
| Tumor localization | Lower third | 79 (36.2%) |
| Middle third | 125 (57.3%) | |
| Upper third | 14 (6.4%) | |
| Tumor invasion | Mucosal | 99 (45.4%) |
| Sub-mucosal | 119 (54.6%) | |
| Lymph node status | Positive | 43 (19.7%) |
| Negative | 175 (80.3%) | |
| Tumor differentiation grade | G1 | 44 (20.2%) |
| G2 | 70 (32.1%) | |
| G3 | 104 (47.7%) | |
| Type of surgery | Total gastrectomy | 38 (17.4%) |
| Subtotal gastrectomy | 180 (82.6%) | |
| Type of lymphanodectomy | D1 | 23 (10.6%) |
| D2 | 195 (89.4%) | |